1-243136168-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_014812.3(CEP170):c.4294A>G(p.Ile1432Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000263 in 152,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I1432T) has been classified as Uncertain significance.
Frequency
Consequence
NM_014812.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CEP170 | NM_014812.3 | c.4294A>G | p.Ile1432Val | missense_variant | 17/20 | ENST00000366542.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CEP170 | ENST00000366542.6 | c.4294A>G | p.Ile1432Val | missense_variant | 17/20 | 5 | NM_014812.3 | P1 | |
ENST00000439562.1 | n.58+213T>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes ? AF: 0.0000263 AC: 4AN: 152038Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000154 AC: 2AN: 129722Hom.: 0 AF XY: 0.0000146 AC XY: 1AN XY: 68414
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000152 AC: 21AN: 1377740Hom.: 0 Cov.: 28 AF XY: 0.0000191 AC XY: 13AN XY: 679526
GnomAD4 genome ? AF: 0.0000263 AC: 4AN: 152038Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74250
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 05, 2024 | The c.4294A>G (p.I1432V) alteration is located in exon 17 (coding exon 16) of the CEP170 gene. This alteration results from a A to G substitution at nucleotide position 4294, causing the isoleucine (I) at amino acid position 1432 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at